NeuroMetrix Inc
NASDAQ:NURO

Watchlist Manager
NeuroMetrix Inc Logo
NeuroMetrix Inc
NASDAQ:NURO
Watchlist
Price: 4.58 USD 5.05% Market Closed
Market Cap: $9.4m

Operating Margin

-289.6%
Current
Declining
by 143.4%
vs 3-y average of -146.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-289.6%
=
Operating Income
$-8.8m
/
Revenue
$3m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-289.6%
=
Operating Income
$-8.8m
/
Revenue
$3m

Peer Comparison

Country Company Market Cap Operating
Margin
US
NeuroMetrix Inc
NASDAQ:NURO
9.4m USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.1B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
184.5B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
139.3B USD
Loading...
US
Stryker Corp
NYSE:SYK
136.2B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
129.3B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57.8B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.6B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.2B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
47.9B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.5B USD
Loading...

Market Distribution

Lower than 90% of companies in the United States of America
Percentile
10th
Based on 14 112 companies
10th percentile
-289.6%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

NeuroMetrix Inc
Glance View

Market Cap
9.4m USD
Industry
Health Care

NeuroMetrix, Inc. engages in the development and manufacture of diagnostic and therapeutic neurostimulation-based medical devices. The company is headquartered in Waltham, Massachusetts and currently employs 23 full-time employees. The company went IPO on 2004-07-22. The firm is engaged in the designing, building and marketing of medical devices that stimulate nerves and analyze nerve response for diagnostic and therapeutic purposes. The company has two principal product categories, which includes point-of-care neuropathy diagnostic tests and wearable neurostimulation devices. Its products include DPNCheck, Quell and ADVANCE System. DPNCheck is a quantitative nerve conduction test that is used to evaluate peripheral neuropathies, such as Diabetic peripheral neuropathy (DPN). Quell a wearable device for symptomatic relief and management of chronic pain. ADVANCE System is a platform for the performance of nerve conduction studies. DPNCheck customers include managed care organizations, endocrinologists, podiatrists and primary care physicians. ADVANCE System customers include occupational health, primary care, internal medicine and many others.

NURO Intrinsic Value
2.36 USD
Overvaluation 48%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-289.6%
=
Operating Income
$-8.8m
/
Revenue
$3m
What is NeuroMetrix Inc's current Operating Margin?

The current Operating Margin for NeuroMetrix Inc is -289.6%, which is below its 3-year median of -146.2%.

How has Operating Margin changed over time?

Over the last 3 years, NeuroMetrix Inc’s Operating Margin has decreased from -27.6% to -289.6%. During this period, it reached a low of -289.6% on Jan 31, 2025 and a high of -27.6% on Dec 1, 2021.

Back to Top